Colloidal formulation of mistletoe extracts in a pharmaceutical flow process for targeted cancer therapy

Publication date

2019

Authors

Leneweit, Gero
Miranda, Bárbara S.
de Matos, Maria B.C.ISNI 0000000506344880
Beztsinna, N.ISNI 0000000505885108
Heyder, ChristophISNI 0000000138837939
Dührkop, Claudia
Nirschl, Hermann
Ekdahl, Kristina Nilsson
Nilsson, Bo
Mastrobattista, E.ORCID 0000-0002-6745-2015ISNI 000000035187179X

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

Keywords

Liposomes, mistletoe, encapsulation of biopharmaceuticals, tumour targeting, triggered release, inhibition of complement activation, Taverne, SDG 3 - Good Health and Well-being

Citation

Leneweit, G, Miranda, B S, de Matos, M B C, Beztsinna, N, Heyder, C, Dührkop, C, Nirschl, H, Ekdahl, K N, Nilsson, B, Mastrobattista, E & Kok, R J 2019, 'Colloidal formulation of mistletoe extracts in a pharmaceutical flow process for targeted cancer therapy', Phytomedicine, vol. 61, no. Supplement 1. https://doi.org/10.1016/j.phymed.2019.09.118